http://search.japantimes.co.jp/cgi-bin/nb20110723n4.html
"These medicines remain a valid treatment option for certain patients with type 2 diabetes," though there is a small increased risk of bladder cancer, the agency said. The risk can be reduced by "appropriate patient selection and exclusion," including regular reviews of how well the drug is working for individual patients, the agency said.
"These medicines remain a valid treatment option for certain patients with type 2 diabetes," though there is a small increased risk of bladder cancer, the agency said. The risk can be reduced by "appropriate patient selection and exclusion," including regular reviews of how well the drug is working for individual patients, the agency said.
